Categories: Latest

TUV Rheinland India enter partnership with AP MedTec Zone to deliver medical devices

Hyderabad, June 18, 2017: TUV Rheinland India, a subsidiary of TUV Rheinland Group, Germany, a worldwide leader in Testing, Training, Inspection, Consulting and Certification, announced today that it has partnered with Andhra Pradesh MedTech Zone(AMTZ), the country’s first Medical Technology Manufacturing Park.
MTZ was recently established at Visakapatnam over an area of 270 acres by the Government of Andhra Pradesh.
As per the terms of the partnership, TUV Rheinland India has been awarded a contract to set up and operate Electro-Magnetic Interference (EMI/EMC) including Anechoic Chambers, Biomaterial, Reliability and Electrical Safety Testing Facilities on Public Private Partnership Mode within AMTZ at an estimated investment of about Rs 85 crore over 4-5 years to support AMTZ’s objective to reduce medical device imports and production cost, partner with industry to deliver the quality medical devices to local market and eventually increase the export of world class medical devices to the international market, a release said here.
The contract was signed by Mr. Thomas Fuhrmann, Managing Director of TUV Rheinland India and Dr.Jitendar Kumar Sharma, Director and CEO of AMTZ.
The creation of AMTZ is based on the fact that medical devices manufacturing requires very high investment facilities which are capital intensive for individual manufacturers to invest upon. With a market size of close to 4 Billion dollars,78 per cent of medical devices in India are imported from other countries, the release said.
AMTZ will house modern 250-300 independent manufacturing units,each over a built-in ready to use area at a very cost effective long-term lease.In addition, the park will have in-house high investment scientific facilities, including state-of-the-art testing laboratories, which would help manufacturers significantly reduce the cost manufacturing thereby creating world class diagnosis with quality products accessible to the common man at affordable prices.

United News of India

The Pharma Times News Bureau

Recent Posts

World Diabetes Day Survey: Diabetologists and Endocrinologists demand for AI-Based Training and Upskilling in Diabetes Care

 A striking 90% of the 3000 Diabetologists and Endocrinologists surveyed, emphasised the importance of continuous…

2 days ago

Doctors warn diabetes patients about risk of smoking

People who smoke are also at much higher risk of developing diabetes compared to non-smokers…

3 days ago

CPHI & PMEC India Expo: Encouraging affordable solutions in India’s march towards a $130 Billion Pharma Market by 2030

17th edition of CPHI& PMEC India Expo to be held from 26th November-28thNovember 2024, at the India…

3 days ago

Sringeri Sharada Equitas Hospital Revolutionizing Cancer Care with the Launch of Low-cost, High Quality Radiation Therapy

The launch signifies Equitas’ redefined commitment to bring world-class cancer radiation therapy accessible to all.…

4 days ago